Challem, Jack, “Vitamin E: High-Doses Reduce The Risk Of Heart Attack” The Nutrition Reporter (May 1996) pp. 1-3;. |
Department of Neurology, University of Rochester Medical Center, “Effects Of Tocopherol And Deprenyl On The Progression Of Disability In Early Parkinson's Disease. The Parkinson Study Group” The New England Journal Of Medicine (Jan. 21, 1993) vol. 328(3):176-183;. |
Agus et al., “Vitamin C Crosses The Blood-Brain Barrier In The Oxidized Form Through The Glucose Transporters” The Journal For Clinical Investigation (Dec., 1997) vol. 100:11,2842-48;. |
Diaz, Marco, N., et al., “Antioxidants And Atherosclerotic Heart Disease” The New England Journal of Medicine vol. 337:408-416;. |
Drachman, David, A., “Treatment Of Alzheimer's Disease—Searching For A Breakthrough, Settling For Less” The New England Journal Of Medicine (Apr. 24, 1997) vol. 336:1245-1247;. |
Hayashi, Eiichi, et al., “Fundamental Studies on Physiological and Pharmacological Actions of L-Ascorbate 2-Sulfate (IV) On the General Pharmacological Acitons of L-Ascorbate 2-Sulfate” Oyo Yakuri 129(1): 131-138, 1976;. |
Jenner, P., “Oxidative Damage In Neurodegenerative Disease” The Lancet (Sep. 17, 1994) vol. 344:796-798n;. |
Lethem, Rosemary, et al., “Antioxidants and Dementia” The Lancet (Apr. 26, 1997) vol. 349:1189-1190;. |
Patterson, John, W., “The Diabetogenic Effect of Dehydroascorbic and Dehydroisoascorbic Acids”, J. Biol. Chem. 183: 81-88, 1950;. |
Patterson, John, W., et al. “Some Effects of Dehydroascorbic Acid on the Central Nervous System”, Am. J. Physiol. 167: 119-126, 1951;. |
Peyser, CX.E., et al., “Trial Of D-Alpha-Tocopherol In Huntington's Disease” American Journal of Psychiatry (Dec. 1995) vol. 152(12):1771-1775;. |
Sano, Mary, et al., “A Controlled Trial Of Selegiline, Alpha-Tocopherol, Or Both As Treatment Of Alzheimer's Disease” The New England Journal Of Medicine (Apr. 24, 1997) vol. 336: 1216-1222. |
Siostrand, “Pharmacological Effects of Dehydroascorbic Acid and Ascorbic Acid in Conscious and Anaesthetized Animals” Acta Physiol. Scand. Suppl. 356:1-79, 1970;. |
Smith, M. A., et al., “Oxidative Damage In Alzheimer's” Nature (Jul. 11, 1996) vol. 382:120-121;. |
Sorg, Olivier, et al., “Inhibition Of Astrocyte Glutamate Uptake By Reactive Oxygen Species: Role Of Antioxidant Enzymes” Molecular Medicine (Jul. 7, 1997) vol. 3:431-440;. |
Tardif, Jean-Claude, et al., “Probucol And Multivitamins In The Prevention Of Restenosis After Coronary Angioplasty” The New England Journal Of Medicine (Aug. 7, 1997) vol. 337:365-372;. |
Vera, Juan Carlos, et al., “Mammalian Facilitative Hexose Transporters Mediate The Transport Of Dehydroascorbic Acid” Nature (Jul. 1, 1993) vol. 364:79-82;. |
Vera et al., “Resolution Of The Facilitated Transport Of Dehydroascorbic Acid From Its Intracellular Accumulation As Ascorbic Acid” The American Society For Biochemistry and Molecular Biology (May 26, 1995) vol. 270:21,23705-12;. |
Welch et al., “Accumulation of Vitamin C (Ascorbate) and Its Oxidized Metabolite Dehydroascorbic Acid Occurs By Separate Mechanisms” The American Society of Biochemistry and Molecular Biology (May 26, 1995) vol. 270, No. 21, 12584-12592;. |
Wilson, “Antioxidant Defense of the Brain: A Role For Astrocytes” The Canadian Journal Physiology Pharmacology (Nov., 1997) vol.: 11-12, 1149-63;. |
Witztum, Joseph, L., “The Oxidation Hypothesis Of Atherosclerosis” The Lancet (Sep. 17, 1994) vol. 344:793-795;. |
Youdim, Moussa, B.H., et al., “Understanding Parkinson's Disease” Scientific American (Jan. 1997) pp. 52-59;. |
Barabas, Judith, et al., (1995) “Ascorbic Acid in Cerebrospinal Fluid: A Possible Protection Against Free Radicals in the Brain.” (abstract), Archives of Gerontology and Geriatrics, vol. 21, No.1, 43-48 (Exhibit). |
Brau, R. H., et al., (1984) “Cerebrospinal Fluid Ascorbic Acid Levels in Neurological Diorders.”. (abstract), Neurosurgery, vol. 14, No. 2, 142-146 (Exhibit 2). |
Rose, Richard C., (1993) “Cerebral Metabolism of Oxidized Ascorbate” (abstract), Brian Research, vol. 628, No. 1-2, 49-55 (Exhibit 3). |
Sadrzadeh, S. et al., (1988) “Hemoglobin-Mediated Oxidant Damage to the Central Nervous System Requires Endogenous Ascorbate.” (abstract) Journal of Clinical Investigation vol. 82, No. 5, 1510-1515 (Exhibit 4). |